What is the personalized medicine biomarkers market size in 2026?

The global personalized medicine biomarkers market is projected to reach US$30.9 billion in 2026.

What drives the personalized medicine biomarkers market?

The personalized medicine biomarkers market is driven by increasing adoption of precision oncology, expansion of genomic sequencing technologies, and rising demand for targeted and patient-specific therapeutic decision-making across chronic and complex diseases.

What is the growth rate for the personalized medicine biomarkers market?

The personalized medicine biomarkers market is poised to witness a CAGR of 15.8% from 2026 to 2033.

What are the key market opportunities?

Key market opportunities include expansion of liquid biopsy applications, integration of artificial intelligence in biomarker discovery, and growing adoption of multi-omics platforms for early disease detection and personalized therapy selection.

Who are the key players in the personalized medicine biomarkers market?

Some of the key market players include Roche Diagnostics, Thermo Fisher Scientific, Illumina, QIAGEN, and Abbott Laboratories.

Table of Content - Personalized Medicine Biomarkers Market Size, Share, and Growth Forecast, 2026

Executive Summary
1. Global Personalized Medicine Biomarkers Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-economic Factors
  1. Global Sectoral Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Tool Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. PESTLE Analysis
5. Porter’s Five Force Analysis
Price Analysis, 2025A
1. Key Highlights
2. Key Factors Impacting Deployment Costs
3. Pricing Analysis, By Biomarker Type
Global Personalized Medicine Biomarkers Market Outlook
1. Key Highlights
  1. Market Volume (Units) Projections
  2. Market Size (US$ Bn) and Y-o-Y Growth
  3. Absolute $ Opportunity
2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2025
  2. Current Market Size (US$ Bn) Analysis and Forecast, 2026 - 2033
3. Global Personalized Medicine Biomarkers Market Outlook: Biomarker Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Biomarker Type, 2020 - 2025
  3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 - 2033
    1. Genomic
    2. Proteomics
    3. Metabolic
    4. Others
  4. Market Attractiveness Analysis: Biomarker Type
4. Global Personalized Medicine Biomarkers Market Outlook: Application
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Application, 2020 - 2025
  3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
    1. Disease Diagnosis
    2. Drug Discovery & Development
    3. Therapeutic Monitoring
    4. Treatment Selection
    5. Others
  4. Market Attractiveness Analysis: Application
5. Global Personalized Medicine Biomarkers Market Outlook: Disease Indication
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Bn) Analysis, By Disease Indication, 2020 - 2025
  3. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026 - 2033
    1. Oncology
    2. Neurology
    3. Diabetes
    4. Autoimmune diseases
    5. Cardiology
    6. Others
    7. Market Attractiveness Analysis: Disease Indication
Global Personalized Medicine Biomarkers Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2020 - 2025
3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2026 - 2033
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Personalized Medicine Biomarkers Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Biomarker Type
  3. By Application
  4. By Disease Indication
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. U.S.
  2. Canada
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 - 2033
  1. Genomic
  2. Proteomics
  3. Metabolic
  4. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Disease Diagnosis
  2. Drug Discovery & Development
  3. Therapeutic Monitoring
  4. Treatment Selection
  5. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026-2033
  1. Oncology
  2. Neurology
  3. Diabetes
  4. Autoimmune diseases
  5. Cardiology
  6. Others
  7. Market Attractiveness Analysis
Europe Personalized Medicine Biomarkers Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Biomarker Type
  3. By Application
  4. By Disease Indication
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 - 2033
  1. Genomic
  2. Proteomics
  3. Metabolic
  4. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Disease Diagnosis
  2. Drug Discovery & Development
  3. Therapeutic Monitoring
  4. Treatment Selection
  5. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026-2033
  1. Oncology
  2. Neurology
  3. Diabetes
  4. Autoimmune diseases
  5. Cardiology
  6. Others
7. Market Attractiveness Analysis
East Asia Personalized Medicine Biomarkers Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Biomarker Type
  3. By Application
  4. By Disease Indication
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. China
  2. Japan
  3. South Korea
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 - 2033
  1. Genomic
  2. Proteomics
  3. Metabolic
  4. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Disease Diagnosis
  2. Drug Discovery & Development
  3. Therapeutic Monitoring
  4. Treatment Selection
  5. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026-2033
  1. Oncology
  2. Neurology
  3. Diabetes
  4. Autoimmune diseases
  5. Cardiology
  6. Others
7. Market Attractiveness Analysis
South Asia & Oceania Personalized Medicine Biomarkers Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Biomarker Type
  3. By Application
  4. By Disease Indication
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 - 2033
  1. Genomic
  2. Proteomics
  3. Metabolic
  4. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Disease Diagnosis
  2. Drug Discovery & Development
  3. Therapeutic Monitoring
  4. Treatment Selection
  5. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026-2033
  1. Oncology
  2. Neurology
  3. Diabetes
  4. Autoimmune diseases
  5. Cardiology
  6. Others
7. Market Attractiveness Analysis
Latin America Personalized Medicine Biomarkers Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Biomarker Type
  3. By Application
  4. By Disease Indication
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 - 2033
  1. Genomic
  2. Proteomics
  3. Metabolic
  4. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Disease Diagnosis
  2. Drug Discovery & Development
  3. Therapeutic Monitoring
  4. Treatment Selection
  5. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026-2033
  1. Oncology
  2. Neurology
  3. Diabetes
  4. Autoimmune diseases
  5. Cardiology
  6. Others
7. Market Attractiveness Analysis
Middle East & Africa Personalized Medicine Biomarkers Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
  1. By Country
  2. By Biomarker Type
  3. By Application
  4. By Disease Indication
3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Biomarker Type, 2026 - 2033
  1. Genomic
  2. Proteomics
  3. Metabolic
  4. Others
5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
  1. Disease Diagnosis
  2. Drug Discovery & Development
  3. Therapeutic Monitoring
  4. Treatment Selection
  5. Others
6. Current Market Size (US$ Bn) Analysis and Forecast, By Disease Indication, 2026-2033
  1. Oncology
  2. Neurology
  3. Diabetes
  4. Autoimmune diseases
  5. Cardiology
  6. Others
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Roche Diagnostics
    1. Overview
    2. Segments and Deployments
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Thermo Fisher Scientific
  3. Illumina, Inc.
  4. QIAGEN N.V.
  5. Abbott Laboratories
  6. Siemens Healthineers
  7. bioMérieux SA
  8. Myriad Genetics
  9. Foundation Medicine
  10. Guardant Health
  11. Exact Sciences
  12. Becton, Dickinson
  13. Agilent Technologies
  14. Bio-Techne Corporation
  15. Sysmex Corporation
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Personalized Medicine Biomarkers Market Size, Share, and Growth Forecast, 2026 - 2033

Quick Links

Our Partners

Secure Payments Through